Robert Bosch Krankenhaus GmbH
Stuttgart, Baden-Wurttemberg 70376
2 studies enrolling now · 3 studies all time
What they study most
Crohn's Disease, Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Multiple Myeloma
Studies at this site
- MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) — Recruiting now
- A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion — Recruiting now
- A Study To Monitor Long-Term Treatment With PF-00547659 — Completed